VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$503.50
arrow_downward
-0.24%(-1.23) 1D
$503.50
0.00% (0.00)
todayPre-market
Closed: Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$504.78
High
$506.01
Low
$496.15
Mkt. cap
127.62B
Avg. vol.
995.37K
Volume
389.00
P/E ratio
29.30
52-wk high
$560.25
52-wk low
$400.74
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
Open
$504.78
High
$506.01
Low
$496.15
Mkt. cap
127.62B
Avg. vol.
995.37K
Volume
389.00
P/E ratio
29.30
52-wk high
$560.25
52-wk low
$400.74
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
UBS raises target for Vertex Pharma stock from USD 585.00 to USD 615.00
Zacks
·
3 hours ago
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
Benzinga
·
16 hours ago
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
GuruFocus
·
17 hours ago
Healthcare Sector Highlights 16 A+ Growth Stocks Including Verte
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com